Cetera Advisors LLC Astrazeneca PLC Transaction History

Cetera Advisors LLC

$0
Q1 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$61.03 - $69.57 $3.33 Million - $3.79 Million	54,488 Added 124.48%	98,262 $6.66 Million
Q4 2023 Feb 13, 2024	BUY	$61.89 - $69.28 $1.47 Million - $1.65 Million	23,756 Added 118.67%	43,774 $2.95 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $26,264 - $29,038	405 Added 2.06%	20,018 $1.36 Million
Q2 2023 Aug 09, 2023	SELL	$69.91 - $75.81 $386,742 - $419,380	-5,532 Reduced 22.0%	19,613 $1.4 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $2,778 - $3,150	44 Added 0.18%	25,145 $1.75 Million
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $267,960 - $348,184	-4,943 Reduced 16.45%	25,101 $1.7 Million
Q3 2022 Nov 10, 2022	BUY	$53.02 - $135.75 $843,389 - $2.16 Million	15,907 Added 112.52%	30,044 $2,000
Q2 2022 Aug 11, 2022	SELL	$59.26 - $71.14 $29,215 - $35,072	-493 Reduced 3.37%	14,137 $934,000
Q1 2022 May 12, 2022	BUY	$55.72 - $67.12 $3,677 - $4,429	66 Added 0.45%	14,630 $971,000
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $291,329 - $344,235	-5,393 Reduced 27.02%	14,564 $848,000
Q3 2021 Nov 16, 2021	BUY	$55.56 - $60.79 $191,793 - $209,847	3,452 Added 20.91%	19,957 $1.2 Million
Q2 2021 Aug 13, 2021	BUY	$48.42 - $60.18 $330,175 - $410,367	6,819 Added 70.4%	16,505 $989,000
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $16,600 - $19,162	-352 Reduced 3.51%	9,686 $482,000
Q4 2020 Feb 17, 2021	BUY	$48.52 - $58.02 $20,475 - $24,484	422 Added 4.39%	10,038 $502,000
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $41,606 - $47,902	784 Added 8.88%	9,616 $527,000
Q2 2020 Aug 13, 2020	SELL	$43.1 - $55.31 $484,875 - $622,237	-11,250 Reduced 56.02%	8,832 $467,000
Q1 2020 May 08, 2020	BUY	$37.79 - $51.33 $65,149 - $88,492	1,724 Added 9.39%	20,082 $897,000
Q4 2019 Feb 10, 2020	SELL	$42.46 - $50.46 $12,568 - $14,936	-296 Reduced 1.59%	18,358 $919,000
Q3 2019 Nov 06, 2019	SELL	$40.12 - $45.47 $26,639 - $30,192	-664 Reduced 3.44%	18,654 $827,000
Q2 2019 Aug 12, 2019	BUY	$37.28 - $41.68 $69,527 - $77,733	1,865 Added 10.69%	19,318 $795,000
Q1 2019 May 06, 2019	BUY	$35.49 - $43.02 $302,658 - $366,874	8,528 Added 95.55%	17,453 $706,000
Q4 2018 Feb 15, 2019	BUY	$36.86 - $41.49 $328,975 - $370,298	8,925 New	8,925 $339,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.05 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.71 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.4 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.37 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.23 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisors LLC with notifications on news.

Account